Skip to main content

ASSEMBLY BIOSCIENCES, INC.

corporate_fare Company Profile

ASSEMBLY BIOSCIENCES, INC.

Exchange: NASDAQSector: Life Sciences

show_chartPrice Chart

Loading chart...

feed ASMB - Latest Insights

ASMB
Apr 22, 2026, 4:22 PM EDT
Filing Type: DEFA14A
Importance Score:
8
Shareholders to Vote on Significant Increase in Stock Incentive and ESPP Shares
Sentiment: Negative
View Wiseek Article
ASMB
Apr 22, 2026, 4:12 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Assembly Biosciences Seeks Shareholder Approval for Significant Equity Plan Expansion, Increasing Potential Dilution by Over 10%
Sentiment: Neutral
View Wiseek Article
ASMB
Mar 19, 2026, 5:04 PM EDT
Filing Type: S-3
Importance Score:
8
Assembly Biosciences Files $400M Universal Shelf Registration and Launches $100M At-The-Market Equity Offering
Sentiment: Negative
View Wiseek Article
ASMB
Mar 19, 2026, 4:15 PM EDT
Filing Type: 10-K
Importance Score:
7
Assembly Bio Reports Reduced Net Loss, Gilead Licenses HPI Program, Raises $166M, Faces HBV Program Setback
Sentiment: Neutral
View Wiseek Article
ASMB
Mar 19, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Assembly Biosciences Reports Significantly Improved 2025 Financials, Extends Cash Runway to 2028
Sentiment: Positive
View Wiseek Article
ASMB
Mar 19, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
8
Assembly Bio Slashes Net Loss, Secures $35M Gilead Licensing Fee, Extends Cash Runway to 2028
Sentiment: Positive
View Wiseek Article